Intendo - medicina INTErna ENDOcrinologia

21/11/2025

!

ECDC recommends vaccinating without delay due to early flu circulation.

Influenza is circulating earlier than usual across the EU/EEA this season - our latest assessment shows detections rising around 3–4 weeks earlier than in the past two years, driven largely by a newly emerged A(H3N2) subclade K strain.

With the full impact of the season still uncertain, early action matters - particularly for people at higher risk of severe disease.

𝗪𝗲 𝗿𝗲𝗰𝗼𝗺𝗺𝗲𝗻𝗱 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵𝗼𝘂𝘁 𝗱𝗲𝗹𝗮𝘆 𝗳𝗼𝗿:

▪️ adults aged 65+,
▪️ pregnant people,
▪️ individuals with chronic conditions or weakened immunity,
▪️ residents of long-term-care or other closed settings,
▪️ healthcare workers and staff working with vulnerable groups.

𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 and 𝗹𝗼𝗻𝗴-𝘁𝗲𝗿𝗺-𝗰𝗮𝗿𝗲 𝗳𝗮𝗰𝗶𝗹𝗶𝘁𝗶𝗲𝘀 are also encouraged to reinforce 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗰𝗼𝗻𝘁𝗿𝗼𝗹 𝗺𝗲𝗮𝘀𝘂𝗿𝗲𝘀 and consider the use of antivirals for outbreak control where appropriate.

Clear communication on 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗶𝗼𝗻, 𝗵𝗮𝗻𝗱 𝗵𝘆𝗴𝗶𝗲𝗻𝗲 𝗮𝗻𝗱 𝗿𝗲𝘀𝗽𝗶𝗿𝗮𝘁𝗼𝗿𝘆 𝗲𝘁𝗶𝗾𝘂𝗲𝘁𝘁𝗲 remains essential as influenza, SARS-CoV-2 and RSV are all expected to circulate in the coming winter months.

Learn more in our:
Press release: https://bit.ly/4p203uk
Threat Assessment Brief: https://bit.ly/485D8XP

24/09/2025

22/08/2025

https://www.facebook.com/share/1FRxNM3Fao/?mibextid=wwXIfr

A world-first lung cancer vaccine is now in human trials — and it could change everything.
Doctors have begun trialing the world’s first mRNA lung cancer vaccine across seven countries.
The vaccine, known as BNT116 and developed by BioNTech, targets non-small cell lung cancer (NSCLC)—the most common and deadliest form of the disease. Using the same mRNA technology that powered COVID-19 vaccines, the jab trains the immune system to identify and destroy cancer cells while minimizing harm to healthy tissue.
Early participants in the trial include 67-year-old Janusz Racz from London, who began treatment at University College London Hospitals.
The phase 1 trial will involve about 130 patients globally, including 20 in the UK, and marks a key step toward potentially making this therapy standard care.
Delivered in weekly doses followed by maintenance injections, the vaccine is combined with immunotherapy to enhance the body’s anti-cancer defenses. Researchers hope this groundbreaking approach will not only treat existing tumors but also prevent recurrence — a major hurdle in lung cancer survival.
If successful, future trial phases could usher in a new era of personalized cancer treatment and dramatically improve outcomes for millions worldwide.

21/08/2025

Eccezionale

Primi risultati dei vaccini contro i tumori del pancreas. Dopo 3 anni il 75% dei pazienti nei quali si è riusciti a stimolare con efficacia il sistema immunitario (17 su 25) è ANCORA VIVO e in gran parte la malattia non si è ripresentata. TRE ANNI. Incredibile.

Voglio proprio vedere chi avrà il coraggio di rifiutare questi vaccini (di cui Trump sta ostacolando lo sviluppo).

https://www.nature.com/articles/s41591-025-03876-4

28/06/2025

Una situazione insostenibile. Farmaco assolutamente necessario per alcuni pazienti, non sostituibile, praticamente non si trova da mesi!!!!!

Il Presidente di AICARM interviene sollecitando interventi immediati per la carenza del Ritmodan

👉 Per leggere il comunicato: https://www.aicarm.it/il-presidente-di-aicarm-interviene-sollecitando-interventi-immediati-per-la-carenza-del-ritmodan/

11/02/2025

𝗦𝗧𝗜 𝗖𝗮𝘀𝗲𝘀 𝗔𝗿𝗲 𝗥𝗶𝘀𝗶𝗻𝗴 𝗔𝗰𝗿𝗼𝘀𝘀 𝗘𝘂𝗿𝗼𝗽𝗲 – 𝗛𝗲𝗿𝗲’𝘀 𝗛𝗼𝘄 𝘁𝗼 𝗦𝘁𝗮𝘆 𝗦𝗮𝗳𝗲

Sexually transmitted infections (STIs) are on the rise across Europe, with cases of chlamydia, gonorrhoea, and syphilis increasing significantly, according to our latest annual epidemiological reports for 2023.

➡️ Chlamydia: most frequently reported bacterial STI in Europe with over 230,000 cases, mainly affecting young women (20–24).

➡️ Gonorrhoea: Nearly 100,000 cases — a 31% jump in one year and 300% since 2014 —spreading among both heteros*xual and LGBTQ+ communities.

➡️ Syphilis: 41,000+ cases, with rates doubling since 2014, especially among men who have s*x with men.

𝗪𝗵𝘆 𝗶𝘁 𝗺𝗮𝘁𝘁𝗲𝗿𝘀:

Some STIs, like gonorrhoea, are becoming harder to treat due to antibiotic resistance. Some infections can have serious long-term health effects if left untreated:

➡️ If left untreated, gonorrhoea can lead to significant health problems, such as pelvic inflammatory disease, and infertility in both men and women.

➡️ Untreated syphilis can cause long-term complications in the heart and nervous system and if a pregnant woman has untreated syphilis, the baby may suffer severe complications.

𝗪𝗵𝗮𝘁 𝘆𝗼𝘂 𝗰𝗮𝗻 𝗱𝗼:
✔ Use protection and look for preventive measures — to reduce the risk of STIs.
✔ Get tested regularly — especially if you have new or multiple partners.
✔ Seek treatment early — most STIs are curable or manageable with prompt care.
✔ Talk to your partners about s*xual health to help prevent further spread.

Raising awareness and taking preventive steps can help stop the rise of STIs!



Read more in our press release and find all of the annual reports on: , , , and linked to it:

https://bit.ly/ECDCSTIs2025

08/02/2024

Hematological malignancies such as Burkitt lymphoma (BL), Hodgkin lymphoma (HL), and diffuse large B-cell lymphoma (DLBCL) cause significant morbidity…

20/11/2023

AGGIORNAMENTO! Carenza Nadololo

Assumi questo farmaco e stai trovando difficoltà a reperirlo?
Leggi l’articolo pubblicato sul blog Aicarm: “NADOLOLO, importazione del farmaco e preparazione galenica “. al link 👉🏼 https://www.aicarm.it/nadololo-importazione-del-farmaco-e-preparazione-galenica/

Troverai informazioni costantemente aggiornate per reperire il Nadololo, un farmaco utilizzato per la terapia delle cardiomiopatie.

Il Nadololo infatti da tempo è stato inserito da AIFA Agenzia Italiana del Farmaco - pagina ufficiale, nella lista dei farmaci temporaneamente carenti e quindi di difficile reperibilità nel territorio italiano.

Per qualsiasi ulteriore informazione scrivici in direct, risponderemo alle tue domande

16/11/2022

https://www.facebook.com/100019356713070/posts/1133856047269608/?

With the cold season approaching, influenza and COVID-19 are back in our lives.
❄️
Protect yourself and others by getting vaccinated.

Find out more 👉https://www.who.int/europe/news-room/events/item/2022/10/12/default-calendar/keeping-covid-19-and-influenza-at-bay-this-autumn-winter-prepare--prevent--protect

28/10/2022

Al contrario di quello che comunemente si pensa, non sempre gli integratori e i preparati naturali da banco sono innocui

Five new cases of jaundice have been associated with the regular consumption of turmeric supplements and teas, with all cases recovering after treatment

22/09/2022

J. Wtewael, The Battle Between the Gods and the Titans New Paxlovid studies, the lowdown on bivalent boosters, Titanic battles, the CDC bl...